首页> 美国卫生研究院文献>Current Controlled Trials in Cardiovascular Medicine >The Patient Remote Intervention and Symptom Management System (PRISMS) – a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial
【2h】

The Patient Remote Intervention and Symptom Management System (PRISMS) – a Telehealth- mediated intervention enabling real-time monitoring of chemotherapy side-effects in patients with haematological malignancies: study protocol for a randomised controlled trial

机译:患者远程干预和症状管理系统(PRISMS)–一种远程医疗介导的干预措施可实时监测血液系统恶性肿瘤患者的化疗副作用:一项随机对照试验的研究方案

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundOutpatient chemotherapy is a core treatment for haematological malignancies; however, its toxicities frequently lead to distressing/potentially life-threatening side-effects (neutropenia/infection, nausea/vomiting, mucositis, constipation/diarrhoea, fatigue). Early detection/management of side-effects is vital to improve patient outcomes, decrease morbidity and limit lengthy/costly hospital admissions. The ability to capture patient-reported health data in real-time, is regarded as the ‘gold-standard’ to allow rapid clinical decision-making/intervention. This paper presents the protocol for a Phase 3 multi-site randomised controlled trial evaluating a novel nurse-led Telehealth intervention for remote monitoring/management of chemotherapy side-effects in Australian haematological cancer patients.
机译:背景门诊化疗是血液系统恶性肿瘤的核心治疗方法。然而,其毒性经常导致令人痛苦的/潜在的威胁生命的副作用(中性粒细胞减少症/感染,恶心/呕吐,粘膜炎,便秘/腹泻,疲劳)。早期发现/管理副作用对于改善患者预后,降低发病率并限制长期/昂贵的住院治疗至关重要。实时捕获患者报告的健康数据的能力被认为是“黄金标准”,可以快速进行临床决策/干预。本文介绍了一项3期多站点随机对照试验的方案,该方案评估了一种由护士领导的新型远程医疗干预措施,用于远程监测/管理澳大利亚血液癌症患者的化疗副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号